In May we released a report co-authored with BIO and BioMedTracker. One of the key take-aways from the report is that patient selection biomarkers, if used successfully, can triple the Likelihood of Approval (LOA) for clinical studies.  Here is the data:


Share this Image On Your Site

Please include attribution to with this graphic.

3x Improvements in Clinical Trial Likelihood of Approval